X

pharmaceuticals

IOL Chemicals and Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/HCB5WuVf8_E Key highlights from IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q4 FY22 Earnings Concall   Management Update: IOLCP is optimistic…

Marksans Pharma Limited Q4 FY22 Earnings Conference Call Insights

Key highlights from Marksans Pharma Limited (MARKSANS) Q4 FY22 Earnings Concall   Q&A Highlights: Vijay Nahar - Individual Investor -…

Lupin Ltd Q4 FY22 Earnings Conference Call Insights

https://youtu.be/KuHcJgOThAg Key highlights from Lupin Ltd (LUPIN) Q4 FY22 Earnings Concall   Q&A Highlights: Pritesh Vora - Mission Street India…

SMS Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights

Key highlights from SMS Pharmaceuticals Ltd (SMSPHARMA) Q4 FY22 Earnings Concall Management Update: SMSPHARMA said its near-term focus remains on…

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Transcript

Torrent Pharmaceuticals Ltd  (NSE:TORNTPHARM) Q4 FY22 Earnings Concall dated May. 25, 2022 Corporate Participants: Sudhir Menon -- Executive Director and…

Aurobindo Pharma Q4 FY 2022 Research Tear Sheet

Aurobindo Pharma Limited is an Indian pharmaceutical company. It was established in the year 1986. The founders include Mr. P.V.…

Aurobindo Pharma Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/ZZNGEHlRimc Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q4 FY22 Earnings Concall Management Update: AUROPHARMA received final approval for 3…

Hikal Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/3z2q_SR1OS4 Key highlights from Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Management Update: HIKAL said its new product launches in…

Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/uTUQ9VpSoiU Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues…

Aurobindo Pharma Ltd (AUROPHARMA) Q4 FY22 Earnings Concall Transcript

Aurobindo Pharma Ltd (NSE: AUROPHARMA) Q4 FY22 Earnings Concall dated May 30, 2022 Corporate Participants: Deepthi Thakur -- Investor Relations Santhanam Subramanian -- Chief…